115 related articles for article (PubMed ID: 15459155)
1. Methacholine and macrolides.
Currie GP; Lee DK
Eur Respir J; 2004 Oct; 24(4):709-10. PubMed ID: 15459155
[No Abstract] [Full Text] [Related]
2. [Guidelines for methacholine provocation testing].
Plantier L; Beydon N; Chambellan A; Degano B; Delclaux C; Dewitte JD; Dinh-Xuan AT; Garcia G; Kauffmann C; Paris C; Perez T; Poussel M; Wuyam B; Zerah-Lancner F; Chenuel B;
Rev Mal Respir; 2018 Sep; 35(7):759-775. PubMed ID: 30097294
[TBL] [Abstract][Full Text] [Related]
3. The utility of methacholine airway responsiveness measurements in evaluating anti-asthma drugs.
Inman MD; Hamilton AL; Kerstjens HA; Watson RM; O'Byrne PM
J Allergy Clin Immunol; 1998 Mar; 101(3):342-8. PubMed ID: 9525450
[TBL] [Abstract][Full Text] [Related]
4. Safety of methacholine challenges in a multicenter pediatric asthma study.
Covar RA; Colvin R; Shapiro G; Strunk R
J Allergy Clin Immunol; 2006 Mar; 117(3):709-11. PubMed ID: 16522478
[No Abstract] [Full Text] [Related]
5. Bronchial plasma exudation after adenosine monophosphate or methacholine challenge.
Belda J; Casan P; Martínez C; Margarit G; Giner J; Homs R; Granel C; Sanchis J
J Asthma; 2005 Dec; 42(10):885-90. PubMed ID: 16393729
[TBL] [Abstract][Full Text] [Related]
6. Problems and progress in measuring methacholine bronchial reactivity.
Banik AN; Holgate ST
Clin Exp Allergy; 1998 Apr; 28 Suppl 1():15-9; discussion 32-6. PubMed ID: 9641585
[No Abstract] [Full Text] [Related]
7. Drug treatment of airway inflammation in asthma.
Blake KV
Pharmacotherapy; 2001 Mar; 21(3 Pt 2):3S-20S. PubMed ID: 11253868
[TBL] [Abstract][Full Text] [Related]
8. Bronchial hyperresponsiveness to methacholine and adenosine 5'-monophosphate, and the presence and degree of atopy in young children with asthma.
Suh DI; Lee JK; Kim CK; Koh YY
Clin Exp Allergy; 2011 Mar; 41(3):338-45. PubMed ID: 21255136
[TBL] [Abstract][Full Text] [Related]
9. Obesity induced bronchopulmonary hyperresponsiveness in Tunisian women.
Chouchane A; Miâdi-Messaoud H; Ghannouchi I; Rouatbi S; Zbidi A; Tabka Z; Ben-Jebria A
Int J Obes (Lond); 2010 Jun; 34(6):1078-85. PubMed ID: 20231846
[TBL] [Abstract][Full Text] [Related]
10. Cost-Effectiveness Analysis of 3 Methacholine Challenge Tests: Importance of Simplified Protocols.
Martínez-Cerón E; García A; Casitas R; Galera R; García-Río F
J Investig Allergol Clin Immunol; 2016; 26(2):121-4. PubMed ID: 27164632
[No Abstract] [Full Text] [Related]
11. Airway hyperresponsiveness to methacholine in subjects with spinal cord injury.
Singas E; Lesser M; Spungen AM; Bauman WA; Almenoff PL
Chest; 1996 Oct; 110(4):911-5. PubMed ID: 8874244
[TBL] [Abstract][Full Text] [Related]
12. Clarithromycin reduces the severity of bronchial hyperresponsiveness in patients with asthma.
Kostadima E; Tsiodras S; Alexopoulos EI; Kaditis AG; Mavrou I; Georgatou N; Papamichalopoulos A
Eur Respir J; 2004 May; 23(5):714-7. PubMed ID: 15176685
[TBL] [Abstract][Full Text] [Related]
13. Dose-related response to inhaled fluticasone propionate in patients with methacholine-induced bronchial hyperresponsiveness: a double-blind, placebo-controlled study.
Noonan MJ; Chervinsky P; Wolfe J; Liddle R; Kellerman DJ; Crescenzi KL
J Asthma; 1998; 35(2):153-64. PubMed ID: 9576141
[TBL] [Abstract][Full Text] [Related]
14. Role of FEF25%-75% as a predictor of bronchial hyperreactivity in allergic patients.
Cirillo I; Klersy C; Marseglia GL; Vizzaccaro A; Pallestrini E; Tosca M; Ciprandi G
Ann Allergy Asthma Immunol; 2006 May; 96(5):692-700. PubMed ID: 16729782
[TBL] [Abstract][Full Text] [Related]
15. [The effect of an oral gold compound, auranofin, on bronchial responsiveness to inhaled methacholine in well-controlled bronchial asthma].
Honma M; Tamura G; Taniguchi Y; Takishima T
Arerugi; 1991 Dec; 40(12):1470-6. PubMed ID: 1793366
[TBL] [Abstract][Full Text] [Related]
16. Effect of regular inhaled beclomethasone on exercise and methacholine airway responses in school children with recurrent wheeze.
Freezer NJ; Croasdell H; Doull IJ; Holgate ST
Eur Respir J; 1995 Sep; 8(9):1488-93. PubMed ID: 8575573
[TBL] [Abstract][Full Text] [Related]
17. The pharmacology of aerosolized airway challenge.
Wagers SS; Irvin CG
Respir Care Clin N Am; 1999 Dec; 5(4):633-48. PubMed ID: 10565885
[TBL] [Abstract][Full Text] [Related]
18. NCS 613, a potent and specific PDE4 inhibitor, displays anti-inflammatory effects on human lung tissues.
Yougbare I; Morin C; Senouvo FY; Sirois C; Albadine R; Lugnier C; Rousseau E
Am J Physiol Lung Cell Mol Physiol; 2011 Oct; 301(4):L441-50. PubMed ID: 21784969
[TBL] [Abstract][Full Text] [Related]
19. Cessation of dexamethasone exacerbates airway responses to methacholine in asthmatic mice.
Stengel PW; Nickell LE; Wolos JA; Snyder DW
Eur J Pharmacol; 2007 Jun; 563(1-3):213-5. PubMed ID: 17374534
[TBL] [Abstract][Full Text] [Related]
20. Duration of bronchoprotection of inhaled ipratropium against inhaled methacholine.
Illamperuma C; Davis BE; Fenton ME; Cockcroft DW
Ann Allergy Asthma Immunol; 2009 May; 102(5):438-9. PubMed ID: 19496252
[No Abstract] [Full Text] [Related]
[Next] [New Search]
